Diagnostic Imaging of Musculoskeletal Diseases A Systematic Approach 1st Edition by Akbar Bonakdarpour, William Reinus, Jasvir Khurana ISBN 1627038647 9781627038645 - Own the ebook now and start reading instantly
Diagnostic Imaging of Musculoskeletal Diseases A Systematic Approach 1st Edition by Akbar Bonakdarpour, William Reinus, Jasvir Khurana ISBN 1627038647 9781627038645 - Own the ebook now and start reading instantly
https://ebookball.com/product/kanski-clinical-ophthalmology-ebook-a-
systematic-approach-9th-edition-by-john-salmon-
isbn-9780702077142-0702077143-248/
https://ebookball.com/product/musculoskeletal-tissue-regeneration-1st-
edition-by-william-pietrzak-isbn-9781597452397-6636/
Diagnostic Imaging
of Musculoskeletal Diseases
A Systematic Approach
13
Editors
Akbar Bonakdarpour William R. Reinus
Department of Radiology Department of Radiology
Temple University Hospital Temple University Hospital
3401 N. Broad Street 3401 N. Broad Street
Philadelphia, PA 19140-5189 Philadelphia, PA 19140-5189
USA USA
[email protected] [email protected]
Jasvir S. Khurana, MD
Department of Pathology
Temple University Hospital
3401 N. Broad St.
Philadelphia, PA 19140-5189
USA
[email protected]
We dedicate this text to Drs. Ernest E. Aegerter, a pathologist, and John A. Kirkpatrick Jr.,
a radiologist. They were among the principal founders of the field of skeletal pathology and
radiology. During their time, their residents and colleagues knew them as great educators with
a dedication and a passion for their work. Their textbook, Orthopedic Diseases, published
initially in 1958 was among the first interdisciplinary works devoted to this field. Dr. Aegerter
and Dr. Kirkpatrick illuminated many aspects of the field of radiology. Today, with the advent
of new technologies, this field has grown to include not only diseases that affect the skeleton
but also those that affect muscles, ligaments, tendons, and also the cartilaginous structures
within joints.
With this text we intend to carry on Dr. Aegerter and Dr. Kirkpatrick’s tradition. We have
recruited only well-known musculoskeletal radiologists and pathologists to participate in the
writing of this book. Each author has been carefully selected for his expertise on the topic about
which he’s been asked to contribute. Each author is known as an experienced and seasoned
teacher. Each author has made a mark on the field.
With this talent we aim to lay the foundation of a useful and worthy teaching text. Our
goal is to create a textbook that is at once readable by the radiology resident experiencing
musculoskeletal radiology for the first time and thorough enough to be used by the practicing
radiologist. We do not intend, however, to present an exhaustive reference work. We leave that
task to other authors.
Instead we aim to provide a text that not only conveys important information about com-
mon and some less common musculoskeletal diseases, but more importantly provides a practi-
cal and systematic approach to analyzing diseases of bones, muscles, tendons, ligaments, and
joints. We will provide with each category a means by which to conceptualize and analyze how
pathology changes their appearance on medical images.
To meet these goals we have organized this text according to major categories of disease:
trauma, infection, tumors and tumor-like conditions, metabolic diseases, endocrine disorders,
dysplastic diseases, and arthritis. Where disease categories overlap, e.g., intraosseous tophus
or brown tumor of bone, we discuss those points under each appropriate heading. Where there
is debate as to the etiology of a disease, we also discuss these issues guiding the reader, to the
best of our ability, to what current thinking has to say about that disease.
We also include a chapter that examines basic interventional techniques that apply to mus-
culoskeletal imaging. Again, the idea is not to provide an exhaustive reference on any one
technique, but instead to give the reader a primer on these techniques and their indications
with guidance for finding further information.
Finally, in recognition of the importance of orthopedic procedures, we include information
on the use, imaging appearance, and pathology affecting prostheses and fixation devices. This
information is essential to the practice of modern radiology.
We hope that the reader will both enjoy reading this text and find the experience profitable
to their knowledge base, both in fact and in concept. We look forward to receiving readers’
impressions, criticisms, and suggestions to improve this text in future editions.
v
vi Preface
Akbar Bonakdarpour
Philadelphia, PA William R. Reinus
Jasvir S. Khurana
Contents
vii
Contributors
ix
x Contributors
Carolyn M. Sofka, MD∗ Associate Professor of Radiology, Weill Medical College of Cor-
nell University, New York; Associate Attending Radiologist, Department of Radiology and
Imaging, Hospital for Special Surgery, New York, USA
Jamshid Tehranzadeh, MD∗ VA Long Beach Health Care System, DMM Health Care Group
# 05/114, 5901 E. 7th Street Long Beach, CA 90822 USA, [email protected]
Colleen Veloski, MD Assistant Professor, Department of Endocrinology and Metabolism,
Temple University School of Medicine, Philadelphia, PA, USA, [email protected]
Seoung-Oh Yang, MD, PhD Professor, Department of Radiology, Eulji University School
of Medicine, Daejeon, South Korea, [email protected]
Paul Zhang, MD Associate Professor of Pathology, Hospital of the University of Pennsylva-
nia, Philadelphia, PA, USA
a b
Fig. 1.1 (a and b) Bone is calcified. The crystal structure of calcium bone developing on fibrous tissue is called intramembranous ossifica-
hydroxyapatite makes bone growth more difficult as compared to other tion and that on cartilage is enchondral (or endochondral) ossification.
organs. Large volumetric growth of bone is achieved by having an inter- (a) shows vertebrae of an embryo that are still cartilage. They will even-
mediate non-mineralized structure (or model) which can grow and then tually be replaced by bone (endochondral ossification). (b) shows the
later mineralize. This model can be of either fibrous tissue or cartilage – mandible forming from fibrous tissue (intramembranous ossification)
of formation and resorption is a common feature of most of long bones and flat bones form by endochondral and
metabolic bone diseases. Among the many effects of aging, intramembranous bone formation, respectively (Fig. 1.1a, b).
the rate of bone formation declines to a greater extent than Some bones, like the clavicle have both kinds of bone for-
the rate of resorption, resulting in progressive bone loss as mation. Both long and flat bones are organized with a hard,
bone remodels. but relatively thin, outer region composed of dense, com-
pact bone called the cortex or cortical bone. Inside the cor-
tex is the marrow cavity containing hematopoietic elements,
Bone Architecture fat, and spongy spicules of bone. The bone spicules are also
referred to as trabecular or cancellous bone (Fig. 1.2).
Bone is a composite tissue consisting of mineral, matrix,
cells, and water. The mineral is an analog of the natu-
rally occurring crystalline calcium phosphate, hydroxyap-
atite. The outer cortices of various bones are fashioned in the
Parts of a Long Bone
form of a hollow tube or a bilaminar plate. The architecture is
strengthened by internal “struts” of trabecular bone that are Epiphysis
oriented either along or perpendicular to the lines of stress.
This kind of design is known in engineering terms as “com- This term refers to the end of a tubular bone, located between
posite” and allows bone to take advantage of the strength of the physeal plate (in developing bone) and the articular carti-
components. Thus, bone resists mechanical compression and lage. In adults, the physeal plate is absent. The portion of the
can deform a great deal before failing. Indeed, it is this abil- bone that the epiphysis would have occupied in the growing
ity to deform that allows the skeleton to absorb the forces of skeleton is arbitrarily referred to by the same name (Fig. 1.3).
movement.
Fig. 1.2 Adult long bone. Sagittal section through the proximal femur
showing the internal structure of the bone. The outer dense compact
bone (cortical bone) and the inner cancellous (trabecular or spongy)
bone are filled with spicules or trabeculae
Bone Marrow
Diaphysis (Shaft)
The medullary cavity is filled with varying proportions of
This refers to the middle, cylindrical portion of a tubular hematopoietic marrow (red marrow) and fat (yellow mar-
bone. There is a thick cortex surrounding a marrow space row). Red marrow is most prevalent in younger age groups
4 F.F. Safadi and J.S. Khurana
Periosteum
Molecular Regulation of Osteoblast Differentiation: is close to the bone, there is a ring-like perimeter called
Osteoblast differentiation is regulated by many secreted clear zone or sealing zone. This zone contains abundant
growth factors, including transforming growth factor-beta microfilaments (actin filaments) but lacks other organelles.
(TGF-β), bone morphogenetic proteins (BMPs), and The formation of the sealing zone is a participation of actin
fibroblast growth factors (FGFs) [6, 7]. Furthermore, tran- filaments together with αv β3 integrin. Into the space bounded
scription factors play fundamental roles in osteoblast differ- by the ruffled border and bone, resorptive substances can be
entiation. Runx-2 (runt-related transcription factor 2)/cbfa-1 secreted [13, 14].
(core-binding factor a1) and osterix are essential transcrip-
tion factors for osteoblast differentiation [8, 9]. Also involved
with osteoblast regulation is leptin, a peptide synthesized Mechanism of Osteoclast-Mediated Bone Resorption
by adipocytes with binding affinity to its receptor in the
hypothalamus. This protein regulates bone formation by a Bone resorption involves protons (hydrogen ions) secreted
central mechanism [10]. by an ATP-driven proton pump in the ruffled border of osteo-
clasts. The enzyme carbonic anhydrase II is essential in the
generation of hydrogen ions. Simultaneously, acid hydro-
Osteocytes lases are released from lysosomes. This combination of the
acid created by the hydrogen ions and proteolytic enzymes
provides optimal conditions for the resorption of bone and
Osteocytes are cells within the substance of bone and are
degradation of collagen. Osteoclasts can move over the bone
derived from osteoblasts (Fig. 1.5). They are said to be
surface creating many such resorptive pits. These pits are
involved in cell signaling and maintaining the viability of the
well visualized by scanning electron microscopy and corre-
bone matrix. It is possible that these cells are important in
spond to the Howship’s lacunae in routine sections.
the translation of mechanical loads to cellular events such as
Osteoclasts have calcitonin (but not PTH or vitamin D)
bone formation.
receptors. They are stimulated by IL-6 (perhaps in combina-
tion with IL-1, IL-3, and IL-11) and RANK ligand. These
Osteoclasts cytokines are produced locally by cells of the osteoblast lin-
eage under the influence of PTH, vitamin D3 , TGF-β, IL-1,
and TNF. [11, 15–17]. The regulation of osteoclast differen-
These are multinucleated cells with 2–100 nuclei per tiation is a subject of intense ongoing study with implica-
cell. Most osteoclasts are closely related to the mono- tions for the treatment of a variety of diseases ranging from
cyte/macrophage hematopoietic progenitor cells. Their gene- osteoporosis to skeletal dysplasias such as osteopetrosis. It
sis requires the presence of osteoprogenitor cells along with a involves numerous cytokines including macrophages colony-
variety of hematopoietic cytokines, such as interleukins 1, 3, stimulating factor (M-CSF), RANK ligand (present on
6, and 11, tumor necrosis factor (TNF), M-CSF, and stem cell osteoblasts), RANK receptor (present on osteoclast precur-
factor. Parathyroid hormone (PTH), 1,25-dihydroxyvitamin sors), and osteoprotegerin (OPG), a decoy protein [18–26].
D3 , transforming growth factor-alpha (TGF-α), and epider-
mal growth factor (EGF) act permissively in their formation,
whereas calcitonin inhibits the formation of osteoclasts [11].
Bone Matrix
Osteoclasts Are the Primary Bone Resorbing Cells
Bone matrix, consists of an organic and an inorganic or
Osteoclasts are mostly found at sites where resorption is tak- mineral component. Forty percentage of the dry weight is
ing place, within “eaten out” cavities in the surface of bone composed of the organic component, called osteoid. This
known as Howship’s lacunae (Fig. 1.5). The cells can also includes collagen, proteoglycans, glycoproteins, phospho-
tunnel through cortical bone creating channels. Osteoclasts lipids, and non-collagenous proteins (see Table 1.1). The
are polarized (the nuclei congregate away from the resorb- inorganic component makes up the remaining 60% of the
ing bone surface), and the cytoplasm of the cell between dry weight of bone and is composed primarily of calcium
the nuclei and the ruffled border is rich in carbonic anhy- hydroxyapatite Ca10 (PO4 )6 (OH)2 . At an ultrastructural level,
drase and in tartrate-resistant alkaline phosphatase (TRAP) bone is once again organized to maximally resist mechan-
[12]. By electron microscopy, there is an abundance of mito- ical forces. Calcium hydroxyapatite crystals are arranged
chondria, lysozomes, and free ribosomes in the cytoplasm. parallel to collagen fibers [27]. The orientation maximizes
Activated osteoclasts show an infolding of the plasma mem- the collagen’s resistance to tensile (stretch) forces and the
brane (ruffled border). At the point where the cell membrane calcium hydroxyapatite’s resistance to compressive forces.
1 Bone Structure and Function 7
Table 1.1 Components of bone matrix Urinary excretion of hydroxyproline (found exclusively in
Bone proteins collagen) and other products of collagen degradation (cross-
Collagens linked products such as pyridinoline and deoxypyridinoline)
Type I collagen – woven and lamellar bone act as markers for collagen breakdown. These measurements
Type II collagen – cartilage
reflect the amounts of bone turnover.
Type III collagen found in certain pathologic conditions
Non-collagenous proteins (synthesized mainly from osteoblasts)
Calcium binding – osteonectin, bone sialoprotein
Enzymes
Adhesion proteins – osteopontin, fibronectin, thrombospondin
Mineralization proteins – osteocalcin
Enzymes – collagenase, alkaline phosphatase, metalloproteinases Alkaline Phosphatase
Cytokines – PG, IL-1, and 6
Growth factors – IGF-1, TGF-β, PDGF Although not generally thought of as a matrix component,
The hydrated (muco)polysaccharide gels
alkaline phosphatase is an osteoblast product (such as osteo-
calcin and osteonectin). There are three related isozymes
that are tissue related and are associated with three sepa-
Diseases which result in abnormal collagen disrupt the rate genes. These are the placental, intestinal, and tissue-
normal mechanical function of bone. Osteogenesis imper- nonspecific forms. The last is seen in high levels in a vari-
fecta, which is caused by abnormal collagen, results in an ety of tissues such as bone, liver, kidney and skin. The
abnormal collagen–calcium hydroxyapatite structure and a role on alkaline phosphatase in biomineralization is still
weak bone matrix. speculative. It has been found in matrix vesicles, but its
exact role is unclear. Serum alkaline phosphatase activity is
increased in growing children, pregnancy, healing fractures,
Paget disease, rickets, osteomalacia, hyperparathyroidism,
Classification of Collagens bone-forming tumors, and certain skeletal metastases. It is
reduced in hypophosphatasia.
Connective tissues contain varying amounts of collagen,
elastin (a related fibrous protein), glycosaminoglycans, and The Hydrated (Muco)Polysaccharide Gels
proteoglycans. Of these, collagen is the most abundant.
Several different types of fibrillar, basement membrane, The functional units of bone extracellular matrix “gels” are
and short chain collagens are recognized. These are the types the glycosaminoglycans (GAGs). Of the several GAGs, four
I–XIII collagens. Each of these differs from each other in main groups are present. Hyaluronic acid, chondroitin and
their biochemical structure. Of the fibrillar collagens, type dermatan sulfates, heparan sulfate and heparin, and keratan
I collagen is found in bone, skin, meniscus, tendon, liga- sulfate. The majority are aggregated to a protein core to form
ment, annulus fibrosis, and joint capsules. About 90% of a proteoglycan. Prior to release from the synthesizing cell,
bone matrix is composed of type I collagen. Bone is also GAGs (except hyaluronic acid) are sulfated. This step allows
the primary organ in which type I collagen is located. There a net negative charge on these molecules. In turn, this charge
are several subtypes of type I collagens. Hydroxylation and serves two functions. First, it keeps the molecules extended,
glycosylation are post-translational modifications of collagen increasing the volume to weight ratio. Second, by attract-
and are specific to bone. These differences or modifications ing osmotically charged cations, it attracts water. This mech-
explain why mineralization only occurs in bone and not in anism creates a gel with very high swelling pressures and
other sites [28]. Type II collagen is located mainly in hyaline tremendous resistance to compression.
cartilage, the vitreous humor of the eye, and the nucleus pul- Highly viscous hyaluronic acid is a major constituent of
posus of the intervertebral disk. The other fibrillar collagens synovial fluid, where it helps in lubrication and reduces fric-
are the “minor” collagens, type III occurs in association with tion. Additionally, it may impede bacteria by its physical
type I and also in tissue undergoing repair. Types V and XI and chemical properties. Its synthesis is thought to be by a
occur in association with types I and II, respectively. Type pathway located in the cell membrane. The remainder of the
IV collagen is the prototype and major component of the GAGs mentioned are biosynthesized within Golgi apparatus
basement membrane. Type VII forms the anchoring filament within the cell cytoplasm.
in epithelial basement membranes, while type VIII is local-
ized to endothelial basement membranes. The least under-
stood class of collagens is the short chain collagens and are Mineralization
comprised of the types VI, IX, and X. Short chain collagens
may function in association with other collagens and have a Calcium hydroxyapatite is the main form of mineral in the
role in cartilage physiology. human. Calcification in the body occurs in several different
8 F.F. Safadi and J.S. Khurana
situations. First, there is the physiologic process of carti- minum intoxication, fluoride intoxication (osteofluorosis),
lage and osteoid mineralization. Second, there is the patho- and phosphate deficiency. The mechanisms of action of alu-
logic extracellular or intracellular “dystrophic” calcification, minum and fluoride are as yet unclear. Mineralization is thus
which occurs in association with inflammation and tissue more than just a straightforward physicochemical process.
damage. Third, there is a “metastatic” calcification, which
occurs in association with altered serum levels of calcium
and phosphate, and finally, calcium can be deposited as a Mineral Deposits
component of crystal forming molecules within the joints in
certain disease states. Pathologic mineralization can be of several different types
Most cases of calcium deposition within the soft tissues (dystrophic, metastatic, or crystal deposition). Calcifica-
are caused by local inflammation, trauma, fat necro- tion deposited in metastatic calcification (associated with
sis, scleroderma, hyperparathryroidism, familial hyperphos- increased serum calcium) is often intracellular. There are sev-
phatemia, sarcoidosis, myeloma, metastases, etc. These eral factors that are important in mineralization (Table 1.2).
encompass both dystrophic and metastatic calcifications and
are typically calcium hydroxyapatite.
Punctate or linear calcification seen radiographically, seen
Remodeling of Bone
along menisci, articular cartilage, or intervertebral disks, is
generally due to calcium pyrophosphate deposition (CPPD
disease). This deposition can very rarely be massive and sim- Bone undergoes “remodeling” throughout life. This involves
ulate tophaceous deposits. In such cases the term tophaceous the coupling of “old bone” resorption and “new” bone for-
pseudogout may be appropriate [29]. mation. Thus all skeletal bone is “renewed” on a continuous
Calcification of osteoid (bone mineralization) differs from basis. This mechanism is important, because of the cyclical
soft tissue calcification in being an orderly process. It is dis- loading and torsional stresses that the skeleton undergoes. In
tributed within the hole zones of collagen molecules. This the absence of renewal, the skeletal bone would fatigue from
method does not disrupt the spatial organization of collagen. repetitive loads within a short period of time.
The process is tightly regulated, but poorly understood. The Bone turnover or remodeling is thought to occur in
mineral is initially deposited as amorphous calcium phos- discrete foci or packets scattered throughout the skeleton.
phate. The initial solid phase is formed at neutral pH. This Each packet takes 3–4 months to complete. Such foci have
phase is randomly and poorly oriented. Subsequently a series been termed bone remodeling units or BRUs by Frost, who
of solid phase transformations occur that lead to poorly crys- described the process in 1964.
talline hydroxyapatite as the final stable solid phase. The About 25% of the metabolically active trabecular and
initiation of mineralization is probably caused by heteroge- about 3% of the cortical bone completely renews itself each
neous nucleation, the active binding of calcium, phosphate, year [15, 30]. The amount of bone added in each remodel-
and calcium phosphate complexes at the nucleation site in the ing cycle, however, reduces slightly with age. This is prob-
matrix rather than by simple precipitation. In mature bone, ably due to a decreased number of osteoblasts and has been
it is possible that poorly crystalline calcium carbonate con- suggested as a possible mechanism for age related (but not
taining hydroxyapatite is deposited rather than an amorphous post-menopausal) osteoporosis.
calcium phosphate or hydroxyapatite. In the adult remodeling takes place by three mechanisms:
Table 1.2 Factors important in mineralization basophilic line – the “cement” or the “reversal” line. This
Collagen Collagen provides oriented support for the newly area is poor in collagen and mineral and has a high content
formed crystals. The post-translational of sulfur.
changes in collagen type I make it possible for
Bone formation is carried out by osteoblasts. The pro-
diffusion of large hydrated ions such as
calcium phosphate into the fibril cess takes approximately 3 months. Osteocytes in small areas
Calcium- Phosphoproteins and sialoproteins in the bone of bone that get cut off by newly forming osteons remain
binding matrix may bind calcium to promote crystal as “interstitial” lamellae. Osteoblastogenesis has identifiable
proteins deposition and growth, thus acting as processes of chemotaxis, proliferation, and differentiation of
nucleators. Crystal growth could then depend
on the conformational change in these proteins osteoblasts. This is then followed by mineralization and the
after deposition. The initiation of cessation of osteoblast activity.
mineralization is coincident with the Mediators of osteoblastic activity and bone formation
depolymerization of proteoglycan molecules. include transforming growth factor-beta (TGF-β), bone GLA
Proteoglycans may inhibit calcification by a
number of mechanisms including shielding of
protein fragments, platelet-derived growth factors A and B
collagen, chemical interaction with collagen (PDGF A and B) all of which are chemotactic for osteoblasts.
side chains, sequestering calcium or phosphate Proliferation of osteoblasts is thought to be mediated by
ions or occupying critical space in the TGF-β, PDGF, IGF I and II, and fibroblast growth factors
molecule. Different phosphoproteins have
varying importance in mineralization
(FGFs). Cytokines that may play a role in the differentia-
Pyrophosphate This is a naturally occurring inhibitor of tion of osteoblasts and the production of alkaline phosphatase
calcification. It has a short half-life due to its activity within these cells include IGF-I and bone morpho-
rapid degradation by pyrophosphatases. genetic protein-2 (BMP-2).
Pyrophosphates are present in body fluids and
“Coupling” or bone formation and bone resorption is
increase the stability of the solution phase of
calcium phosphate. Diphosphonates are unexplained. There is emerging evidence that suggests that
pyrophosphate analogs and are powerful “osteoclastogenic” cytokines such as IL-6, IL-1, and IL-11
inhibitors of calcification in large doses as well as “osteoblastogenic” cytokines such as leukemia
Bone Gla Osteocalcin is a highly conserved protein which inhibitory factor may be stimulated together by the same sig-
proteins is abundant in bone matrix. Because of its Gla
residues, it is able to bind calcium, but its role nal transduction pathway. Glycoprotein 130 is a molecule
in mineralization is controversial present in this pathway and is involved in the transduc-
Lipids and Within bone there are acid phospholipids that tion of the signal delivered by each of these cytokines. Sex
proteolipids form complexes with calcium phosphate and steroids inhibit, whereas parathyroid hormone and vitamin
could, thereby, influence mineralization. These
D3 increase glycoprotein 130 in experimental models [15,
substances have the capacity to bind to
calcium 30]. This model, if validated further, would conveniently
Alkaline This is an ectoenzyme produced by osteoblasts explain bone formation–resorption coupling as well as coin-
phosphatase and is likely to be involved with the cide with the various acknowledged facts about the role of
mineralization process. Patients with these hormones in bone turnover.
decreased amounts of enzyme
(hypophosphatasia) have impaired Another mechanism that may explain “coupling,” is the
mineralization (see osteomalacic syndromes in release of osteoblast-stimulating factors such as IGF I and
metabolic bone disease). Alkaline phosphatase II and TGF-β during the osteoclastic process. Coupling is
may be involved in the degradation of the rationale for the counterintuitive, but clinically vali-
inorganic pyrophosphate, thus providing a
sufficient level of organic phosphate for dated method of treating osteoporosis by giving parathyroid
mineralization to proceed hormone.
Several diseases of bone are superimposed on this nor-
mal cellular remodeling sequence. In diseases, such as
of osteoclasts. The trigger for resorption includes the primary hyperparathyroidism, hyperthyroidism, and Paget
stimulatory cytokines IL-1 and IL-6 produced by osteoblasts, disease, there is osteoclast activation. There is also a com-
as well as perhaps, the integrin–RGD sequence interaction pensatory and relatively balanced increase in bone formation,
as well as multiple factors such as transcription factors and because of coupling.
membrane proteins. Other conditions are due to abnormal coupling. Decreased
The osseous defect created by osteoclastic resorption is bone formation after resorption is seen in the osteolytic
filled in by fibrovascular tissue. The fibrovascular core con- lesions of myeloma, where there may be a defect in
tains pericytes, loose connective tissue, macrophages, mes- osteoblast maturation. In solid tumors and in elderly patients
enchymal stem cells, and undifferentiated osteoprogenitor with age-related osteoporosis there may be similar mecha-
cells. The outer edge of the osteon (where resorption ends nisms at work. Osteoblastic activity in the absence of prior
and bone formation first starts) is marked by an intensely osteoclastic activation is thought to occur in some special
10 F.F. Safadi and J.S. Khurana
situations such as osteoblastic metastases, e.g., prostate example, IL-1, IL-6, and E-series prostaglandins. The net
carcinoma metastases, and in bones’ response to fluoride result of exposure to PTH is osteoclast activation and the ini-
therapy. tiation of bone resorption leading to calcium release from
bone.
Additionally, there is evidence to suggest, that in certain
The Regulation of Bone and Cartilage situations PTH stimulates bone formation. When adminis-
tered continuously, it increases osteoclastic resorption and
Endocrine suppresses bone formation. When administered in low doses,
intermittently, it stimulates bone formation without resorp-
• Parathyroid hormone (PTH) and PTHrP tion. This bone-forming effect of PTH has been termed the
• Calcitonin anabolic effect. This anabolic effect too (like the resorptive
• Vitamin D effect) is probably indirect and mediated via substances such
• Vitamin A as IGF-1, TGF-β. Although the anabolic effect of PTH is
• Estrogens dependent on intermittent administration, when serum level
• Androgens of PTH is maintained high even for a few hours it initiates
• Growth hormone (GH) processes leading to new osteoclast formation, and the con-
sequent bone resorption that overrides the effects of acti-
vating genes that direct bone formation. Identification of
Paracrine/Autocrine
PTH-related protein (PTHrP) expression by cells early in the
osteoblast progenitor cells, and its action through the PTH-
• Proteoglycans
1 receptor (PTH1R) upon mature osteoblastic cells, together
• Glyco- and phosphoproteins
with the observation that PTHrP+/– mice are osteoporotic,
• Gamma-carboxyglutamic acid proteins
raise the possibility that PTHrP is a crucial paracrine regula-
• Proteolipids
tor of bone formation.
• Growth factors
• Transforming growth factor-beta (TGF-β)
• Bone morphogenetic protein (BMP) Calcitonin
• Insulin-like growth factors (IGF I and II)
• Epithelial growth factor Calcitonin is a peptide hormone produced by the thyroid
• Fibroblast growth factor parafollicular C cells. Its synthesis and secretion is under the
• Platelet-derived growth factor (PDGF A and B) influence of extracellular calcium levels and certain gastroin-
testinal hormones such as gastrin. It is encoded by a complex
• Other cytokines (interleukins IL)
gene that undergoes alternate splicing. This gene is respon-
sible for several other peptides such as a calcitonin gene-
Parathyroid Hormone related peptide.
Calcitonin causes a short lived fall in plasma calcium.
Parathyroid hormone (PTH) is an 84-amino acid, single- It acts via a receptor to stop the resorption of bone. These
chain polypeptide (called PTH 1-84). It is synthesized in the receptors are present on osteoclasts, preosteoclasts, mono-
parathyroid gland from a biosynthetic precursor pro-PTH. cytes, and certain tumor cells. The major effect on block-
PTH acts on bone, intestine, and kidney. In the latter two, ing of bone resorption, however, is probably via the mature
it enhances calcium resorption. It is also involved in the osteoclast. The mechanism of action is via enhancement of
metabolism of phosphate, bicarbonate, ammonium, magne- adenylate cyclase and stimulating cAMP accumulation. In
sium and in the regulation of acid–base homeostasis in the addition, calcitonin may have mitogenic effect on bone cells.
body. The actions of PTH are influenced by several factors Calcitonin also promotes renal calcium excretion. Its effects
such as 1,25-dihydroxyvitamin D3 , IL-1, TGF-α, EGF. The on calcium homeostasis are lost after 24–48 h. This loss of
production of several of these substances is in turn under the effectiveness can be reduced by simultaneous administra-
control of PTH in a complicated interrelated web. tion of corticosteroids. A possible role of calcitonin in cal-
The best known effect of PTH is osteoclast activation and cium homeostasis is to maintain normocalcemia after a large
subsequent bone resorption. Receptors for PTH are found calcium-containing meal.
on pre-osteoblasts, osteoblasts, and chondrocytes. They are The absence of significant changes in bone mineral den-
not, however, present on osteoclasts. This supports the sity caused by decline or overproduction of calcitonin in
notion, that the action of PTH on the latter is dependent humans has raised the question, whether the pharmacolog-
on the osteoblasts for the production of other cytokines, for ical action of calcitonin as an inhibitor of bone resorption is
1 Bone Structure and Function 11
also of physiological relevance. New data suggest that calci- effect. Several years ago, it was discovered that an imbal-
tonin has a dual action as an inhibitor of bone remodeling, ance of vitamin A during embryonic development has dra-
which may explain, at least in part, why alterations of calci- matic teratogenic effects. These effects have since been
tonin serum levels in humans do not result in major changes attributed to vitamin A’s most active metabolite, retinoic acid
of bone mineral density [31]. (RA), which itself profoundly influences the development
Calcitonin has a role in the therapy of hypercalcemia of of multiple organs including the skeleton. Retinoid signal-
malignancy, in Paget disease, and in osteoporosis. In this ing involves several components, including the skeletogenic
context, it should be mentioned that there is evidence to sug- master regulatory factors, Sox9, and Cbfa1.
gest that the osteoclasts of Paget patients are hyperresponsive
to calcitonin, and remain so for longer periods of time than
Estrogens
do control cells. The molecular mechanisms for this hyperre-
sponsivity is unknown [32].
In experimental situations, reduced estrogen leads to bone
loss. This may be a direct effect on osteoblasts and possi-
Vitamin D bly osteoclasts, although it could be mediated via PTH and
calcitonin.
Ergosterol and 7-dehydrocholesterol are the precursors for
this hormone/vitamin. These compounds are stored in the
Androgens
skin, transported in the body via an alpha-globulin-binding
protein or vitamin D-binding protein (DBP) and become acti-
These act to maintain bone mass through action via receptors
vated by ultraviolet light with a wavelength of 315 nm. This
on osteoblasts. There is an inhibition of the action of PTH
activation generates calciferol and cholecalciferol, respec-
and calcitonin.
tively. These substances are hydroxylated in the liver in the
presence of magnesium to yield 25-hydroxyvitamin D and
then converted further in the proximal tubule of the kid- Growth Hormone
ney to its active form: 1,25-dihydroxyvitamin D. This hor-
mone/vitamin is one of the prime controllers of calcium The effect of growth hormone on bone is mostly mediated
metabolism in the gut, proximal tubule, and bone. Reduced via insulin-like growth hormone (IGF). There may, how-
calcium and increased PTH are the kidneys to increase 1,25- ever, be a direct effect through growth hormone receptors on
dihydroxyvitamin D production. osteoblasts and chondrocytes.
The actions of 1,25-dihydroxyvitamin D include stim-
ulation of calcium-binding proteins, increased osteocal- Proteolipids
cin production, increased osteoclastic activation and bone
resorption, monocytic maturation, myelocytic differentia- These are membrane proteins complexed with acidic phos-
tion, skin growth, and insulin secretion. Lack of vitamin D pholipids. They cause hydroxyapatite deposition. They have
results in impaired mineralization of newly formed bone – a high concentration in the matrix vesicles, where they are
the clinical disease resulting from this is known as rick- thought to have a role in the export of protons and the import
ets in children, and osteomalacia in adults. In both of these of calcium and phosphate across the cell membrane.
conditions, osteoid, the proteinaceous bone matrix, accumu-
lates, but does not mineralize. Excessive vitamin D leads to
increases in bone resorption and hypercalcemia. Growth Factors
Vitamin D works through specific vitamin D receptors.
Receptor sites for 1,25-dihydroxyvitamin D have been iden- Transforming Growth Factor-Beta: TGF-β
tified on several cells. Gene errors in several forms of rick-
ets have been found to occur within these nuclear receptors. TGF-β was initially isolated from “transformed” neoplastic
There is also a suggestion that post-menopausal osteoporo- cells in tissue culture studies. Two “factors” were isolated
sis may be genetically predetermined by the polymorphisms and named TGF-α and -β. TGF-α is not found in bone and is
present in the vitamin D receptor gene [33]. now called epidermal growth factor. There are three human
isoforms of TGF-β. The largest store of TGF-β in the body
is the bone matrix. The current hypothesis is that TGF-β
Vitamin A induces bone formation during remodeling. The action of
TGF-β in bone induction, however, may be only in conjunc-
Retinoids, in excess, decrease the formation of bone and car- tion with other factors such as the bone morphogenetic pro-
tilage matrix. A deficiency of vitamin A has the opposite teins (BMPs).
12 F.F. Safadi and J.S. Khurana
4. Hohling HJ, Barckhaus RH, Drefting ER, Quint P, Athoff J. Quan- c-Jun N-terminal kinase in T cells. J Biol Chem 1997; 272(40):
titative electron microscopy of the early stages of cartilage miner- 25190–25194.
alization. Metab Bone Dis Relat Res 1978; 1:109–114. 25. Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogen-
5. Landis WJ, Song MJ, Leith A, McEwen L, McEwen BF. Mineral esis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mech-
and organic matrix interaction in normally calcifying tendon visu- anism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
alized in three dimensions by high-voltage electron microscopic Endocrinology 1998; 139(3):1329–1337.
tomography and graphic image reconstruction. J Struct Biol 1993; 26. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation
110(1):39–54. factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory
6. Khan SN, Bostrom MP, Lane JM. Bone growth factors. Orthop factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci
Clin North Am 2000; 31(3):375–388. USA 1998; 95(7):3597–3602.
7. Rodan GA. Control of bone formation and resorption: biological 27. Sela J, Amir D, Schwartz Z, Weinberg H. Ultrastructural tissue
and clinical perspective. J Cell Biochem Suppl 1998; 30–31:55–61. morphometry of the distribution of extracellular matrix vesicles in
8. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 remodeling rat tibial bone six days after injury. Acta Anat (Basel)
results in a complete lack of bone formation owing to maturational 1987; 128(4):295–300.
arrest of osteoblasts. Cell 1997; 89(5):755–764. 28. Ressoret J, De Crombrugghe B. Type I collagen. In: JP Bilezikian
9. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for LGR, GA Rodan (Eds.), Principels of Bone Biology, 2nd ed. San
cleidocranial dysplasia syndrome, is essential for osteoblast differ- Diego: Academic Press, 2002; 189–210.
entiation and bone development. Cell 1997; 89(5):765–771. 29. Ishida T, Machinami R. Reactive bone and cartilage forming pro-
10. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation cesses of the hands and feet. Pathol Int 1995; 45(12):975–976.
through a hypothalamic relay: a central control of bone mass. Cell 30. Manolagas SC, Bellido T, Jilka RL. New insights into the cellular,
2000; 100(2):197–207. biochemical, and molecular basis of postmenopausal and senile
11. Takahashi N, Yamana H, Yoshiki S, et al. Osteoclast-like cell for- osteoporosis: roles of IL-6 and gp130. Int J Immunopharmacol
mation and its regulation by osteotropic hormones in mouse bone 1995; 17(2):109–116.
marrow cultures. Endocrinology 1988; 122(4):1373–1382. 31. Huebner AK, Schinke T, Priemel M, et al. Calcitonin deficiency
12. Watanabe H, Yanagisawa T, Sasaki J. Cytoskeletal architecture in mice progressively results in high bone turnover. J Bone Miner
of rat calvarial osteoclasts: microfilaments, and intermediate fila- Res 2006; 21(12):1924–1934.
ments, and nuclear matrix as demonstrated by detergent perfusion. 32. Mundy GR, Boyce B, Hughes D, et al. The effects of
Anat Rec 1995; 243(2):165–174. cytokines and growth factors on osteoblastic cells. Bone 1995;
13. Horne WC. Toward a more complete molecular description of the 17(2 Suppl):71S–75S.
osteoclast. Bone 1995; 17(2):107–109. 33. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density
14. Sakai D, Tong HS, Minkin C. Osteoclast molecular phenotyping from vitamin D receptor alleles. Nature 1994; 367(6460):284–287.
by random cDNA sequencing. Bone 1995; 17(2):111–119. 34. Urist MR, Mc LF. Osteogenetic potency and new-bone formation
15. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone by induction in transplants to the anterior chamber of the eye.
remodeling. Emerging insights into the pathophysiology of osteo- J Bone Joint Surg Am 1952; 34-A(2):443–476.
porosis. N Engl J Med 1995; 332(5):305–311. 35. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan
16. Ohsaki Y, Takahashi S, Scarcez T, et al. Evidence for an DS. Bone morphogenetic protein-1: the type I procollagen
autocrine/paracrine role for interleukin-6 in bone resorption by C-proteinase. Science (New York) 1996; 271(5247):360–362.
giant cells from giant cell tumors of bone. Endocrinology 1992; 36. Reddi AH. BMP-1: resurrection as procollagen C-proteinase. Sci-
131(5):2229–2234. ence (New York) 1996; 271(5248):463.
17. Roodman GD, Kurihara N, Ohsaki Y, et al. Interleukin 6. A poten- 37. Urist MR, DeLange RJ, Finerman GA. Bone cell differ-
tial autocrine/paracrine factor in Paget’s disease of bone. J Clin entiation and growth factors. Science (New York) 1983;
Invest 1992; 89(1):46–52. 220(4598):680–686.
18. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient 38. Urist MR, Sato K, Brownell AG, et al. Human bone morpho-
mice develop early onset osteoporosis and arterial calcification. genetic protein (hBMP). Proc Soc Exp Biol Med (New York) 1983;
Genes Dev 1998; 12(9):1260–1268. 173(2):194–199.
19. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential 39. Urist MR, Wallace TH, Adams T. The function of fibrocartilagi-
for osteoclast and lymph node development. Genes Dev 1999; nous fracture callus. Observations on transplants labelled with tri-
13(18):2412–2424. tiated thymidine. J Bone Joint Surg 1965; 47:304–318.
20. Hughes AE, Ralston SH, Marken J, et al. Mutations in 40. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone
TNFRSF11A, affecting the signal peptide of RANK, cause famil- formation: molecular clones and activities. Science (New York)
ial expansile osteolysis. Nat Genet 2000; 24(1):45–48. 1988; 242(4885):1528–1534.
21. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone 41. Cook SD, Salkeld SL, Rueger DC. Evaluation of recombinant
loss and joint destruction in adjuvant arthritis through osteoprote- human osteogenic protein-1 (rhOP-1) placed with dental implants
gerin ligand. Nature 1999; 402(6759):304–309. in fresh extraction sites. J Oral Implantol 1995; 21(4):281–289.
22. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator 42. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recom-
of osteoclastogenesis, lymphocyte development and lymph-node binant human osteogenic protein-1 on healing of segmental
organogenesis. Nature 1999; 397(6717):315–323. defects in non-human primates. J Bone Joint Surg Am 1995;
23. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is 77(5):734–750.
a cytokine that regulates osteoclast differentiation and activation. 43. Shimizu T, Okayama A, Inoue T, Takeda K. Analysis of
Cell 1998; 93(2):165–176. gene expression during staurosporine-induced neuronal differ-
24. Wong BR, Rho J, Arron J, et al. TRANCE is a novel lig- entiation of human prostate cancer cells. Oncol Rep 2005;
and of the tumor necrosis factor receptor family that activates 14(2):441–448.
Chapter 2
Akbar Bonakdarpour
Abstract This chapter begins with a brief introduction to diseases can be considered metabolic in nature. Narrower
bone metabolism. The main focus is discussing generalized definitions of the so-called “metabolic diseases of bone” are
diminished bone density (GDBD), but examples of general- almost as numerous as the number of authors who write
ized increased bone density are also briefly presented. Since about them. Endocrine dysfunctions, Paget disease, various
various causes of GDBD are not considered in the WHO nutritional problems, some hereditary diseases of bone, and
definitions, a radiologic classification based on pathophysi- even other categories of disorders have been included under
ology of GDBD will follow, complementing the WHO def- this heading. In this chapter we will limit discussion to dis-
initions and distinguishing osteoporosis from osteomalacia, eases that cause generalized reduction in bone mineral and
osteolysis, and marrow proliferative disorders. The primary regional osteoporosis.
and secondary osteoporoses are discussed. Diagnostic imag- Metabolic causes of increased bone density such as hyper-
ing of osteoporosis by radiography, dual X-ray absorptiom- vitaminosis D and fluorosis will be very briefly mentioned as
etry (DXA), quantitative CT analysis, microcomputerized prototypes.
tomography, quantitative ultrasonography, and MRI is briefly An attempt will be made to correlate the 1994 World
reported. The major risk of advanced osteoporosis is fracture Health Organization (WHO) definitions of osteoporosis
of the spine, hip, and less frequently other bones. A summa- with radiopathophysiological classification of “generalized
rized treatment of osteoporosis is followed by discussion of diminished bone density” (GDBD). The main purpose is to
osteomalacia, rickets, hypervitaminoses D and A, as well as make the two systems complementary. The WHO “defini-
fluorosis. tions” are basically concerned with various stages of osteo-
porosis. Admittedly most, but not all cases of “generalized
Keywords Metabolic bone disease • Osteoporosis • Osteo- diminished bone density” (GDBD) are due to osteoporosis.
malacia • Rickets • Marrow packing disorders • WHO defi- Our approach will give a road map to distinguish osteo-
nitions of osteoporosis • Dual X-ray absorptiometry • Quan- porotic cases from nonosteoporotic entities, such as vari-
titative CT analysis • MRI BMD measurement • Scurvy • ous forms of osteomalacia, hyperparathyroidism, multiple
Reflex sympathetic dystrophy • Osteogenesis imperfecta • myeloma, Gaucher disease, and other forms of GDBD.
Homocystinuria • Osteomalacia • Rickets • Hypophosphata-
sia • Hypervitaminosis D • Hypervitaminosis A • Fluorosis
Bone Metabolism
Introduction
A brief discussion of metabolism of calcium, phosphorus,
Metabolic diseases of bone, strictly defined, are those dis- parathyroid hormone (PTH), and vitamin D will help to bet-
orders of the skeletal system related to abnormalities of all ter understand metabolic bone disease, its diagnosis, and
synthetic (anabolic) and degradative (catabolic) biochemi- treatment.
cal reactions in the body. With this definition, most skeletal
Calcium Metabolism
Akbar Bonakdarpour ()
Department of Radiology, Temple University School of Medicine,
Philadelphia, PA 19140, USA There are between 1,000 and 2,000 g of calcium in the aver-
e-mail: [email protected] age adult human body, 98% of which is in the skeleton. In
adults, 80% of calcium is in cortical bone and 20% in tra- PTH promotes calcium resorption from bone.
becular bone. Calcium exists in three forms in plasma: as In the kidneys, PTH inhibits reabsorption of sodium, cal-
ions, bound to proteins, and as diffusible complexes. The cium, phosphate, and bicarbonate ions in the proximal tubule
normal range of calcium in serum is between 9 and 11 mg of the nephron. It stimulates calcium reabsorption in the dis-
per 100 cm3 (US Food and Drug Administration, Investiga- tal tubule. PTH also stimulates renal synthesis of 1,25(OH)2
tors Manual 2001). At homeostasis, urinary excretion of cal- D3 (1,25-dihydroxycholecalciferol) from hepatically formed
cium typically equals net dietary intake. Serum calcium is 25 hydroxycholecalciferol.
increased by PTH and vitamin D and is decreased by acute PTH also maintains serum magnesium level. (The normal
hypercalcemia and calcitonin. range of magnesium in the blood is 1.8–3.6 mg per 100 cm3
Three organ systems have roles in calcium (Ca2+ ) (US Food and Drug Administration, Investigators Manual
metabolism: 2001).) Magnesium influences secretion of PTH but is much
less active than calcium.
1. GI tract: calcium is absorbed primarily in the proximal
small bowel (both vitamin D and PTH influence calcium
absorption).
2. Kidneys: control calcium excretion by glomerular filtra- Vitamin D Metabolism
tion and tubular reabsorption. PTH and vitamin D con-
trol the latter process. The most active form of vitamin D Vitamin D leads to an increase in serum calcium and phos-
is [1,25(OH)2 cholecalciferol]. Cholecalciferol is vitamin phate, and can be derived from two main sources. Vita-
D3. Its first hydroxylation occurs in the liver and the sec- min D3 is produced as a result of ultraviolet light exposure
ond one occurs in the kidney to produce the most active to the skin, whereas vitamin D2 is obtained from dietary
form of vitamin D. sources.
3. Bones: PTH and vitamin D cause resorption of calcium The primary active form of vitamin D is [1,25(OH)2
from mineralized matrix. Calcitonin is produced by the cholecalciferol or dihydroxycholecalciferol], made in the
parafollicular cells of the thyroid glands and opposes the kidneys. Cholecalciferol is vitamin D3, which in the liver
actions of PTH, thus decreasing the resorption of cal- modifies to 25-hydroxycholecalciferol and in the kidney
cium from bone. Calcitonin is secreted in response to an transforms to the most active form. This form of vitamin D
increase in serum calcium but does not play an important elevates plasma calcium and phosphate levels through sev-
role in normal calcium homeostasis. eral actions.
thus routinely used in the clinical evaluation of patients. In over their lifetime. Peak BMD is higher and bone loss
particular, they may be useful for monitoring osteoporosis is of smaller magnitude (20–30%) in men. The rate at
therapy. which this occurs is under the influence of several factors,
including activity, diet, tobacco use, and the presence of
estrogen.
Postmenopausal women tend to lose bone mineral more
Bone Density rapidly than do the premenopausal women. The accelerated
postmenopausal bone loss may cause an additional 2–3%
Maintenance of bone mineral depends upon a balance decline in bone mineral content per year. It occurs initially
between bone synthesis by osteoblasts and bone resorption in the trabecular and then in the cortical compartment. This
by osteoclasts. Normal bone density is related to a balance phase of rapid bone loss eventually decreases and gradually
among the elaboration of osteoid, the mineralization of the reaches a plateau after 8–10 years. In post-oophorectomy
osteoid, and the physiologic bone lysis. These functions cases, bone loss has been reported to be as high as 12% over
are controlled directly or indirectly by hormonal and bio- a 2-year period.
chemical factors beyond and within the bone. A change in In men and women, the process of protracted bone loss
the rate of any of these functions, without a corresponding (involutional osteoporosis) accelerates after the age of 70
adjustment in the rate of the others, causes an imbalance years. Hormonal imbalances have different effects on the
that either increases or decreases bone density. Clinically, development of osteoporosis in men. Testicular secretory
decreased bone density is more important, because it is function declines slowly. Even in very old men, the aver-
much more common than increased bone density. age level of total testosterone is only 20% lower than
The healthy human accumulates bone mass from birth in young men. In contrast, concentrations of bioavailable
until young adulthood. Peak bone mass and consequently testosterone are 50–60% lower than those found in young
peak bone density are achieved around the age of 30 years. men. This leads to bone mineral loss, higher levels of bio-
This peak is influenced by a number of factors, including chemical markers of bone turnover, and higher prevalence
diet, sun exposure, race, and sex. In general, blacks attain of fractures.
higher bone mass than do Caucasians and Asians. Peak bone At the tissue level, increased bone resorption results in
density is higher in men. the perforation and disappearance of trabeculae (Fig. 2.1).
Normally, once peak bone mass is achieved, there is When the trabeculae disappear, the metabolically active sur-
almost a decade of stability where bone density remains face available for osteoclasts decreases and bone loss tends
unchanged. During this stable period, there is normal bone to slow down.
turn over (remodeling or coupling), which means bone There are three distinct types of generalized diminished
resorption and bone production are balanced. Bone remodel- bone density: osteoporosis, osteomalacia, and osteolysis.
ing continues during the entire life and it occurs in compact Each entity has different causes and will be described in more
or cortical bone as well as trabecular or medullary bone. At detail in this chapter. Here we introduce them briefly and they
maturity, 80% of bone is cortical and 20% is trabecular. Nor- will be discussed in more detail later.
mal bone remodeling (coupling) affects 2–3% of the whole In osteoporosis and some cases of generalized osteolysis,
skeletal mass per year. such as primary hyperparathyroidism, there is diffuse bone
loss, but there is no chemical abnormality in the composi-
tion of bone. In other words, one gram of normal bone has an
identical chemical composition to one gram of osteoporotic
Generalized Diminished Bone Density or bone from a patient with hyperparathyroidism. On the
other hand, in osteomalacia, where there is diminished min-
In young adults, bone resorption and bone formation are in eralization of the osteoid, the chemical composition of bone
equilibrium and bone density remains stable. When bone is abnormal.
loss outweighs bone gain, bone density decreases. In both Osteoporosis is defined as a nonfocal reduction of bone
genders, around 40 years of age the process of involutional mass per unit volume (cubic centimeter) without change
osteoporosis (bone loss) starts and bone density begins to in chemical composition of bone. Osteoporosis can also
gradually decrease. Involutional osteoporosis has an ini- be defined as a chronic, progressive disease characterized
tial rate of 0.3–0.5% of bone loss per year. This pro- by low bone mass, microarchitectural bone deterioration
cess continues throughout life and accelerates with age. (Fig. 2.1), and decreased bone strength leading to bone
Women experience a superimposed, transient period of fragility and increased fracture risk.
postmenopausal, accelerated bone loss. Women lose about Regional osteoporosis occurs in cases of disuse osteoporo-
35% of their cortical and 50% of their trabecular bone sis (such as immobilization), reflex sympathetic dystrophy,
18 A. Bonakdarpour
A B
Fig. 2.1 Osteoporosis. a – Low power microscopic section of normal images is a reflection of these histological aberrations. a and b are cour-
bone in an iliac crest biopsy. b – Microscopic section of osteoporotic tesy of Dr. Peter Bullough, Hospital for Special Surgery, New York and
bone in an iliac crest biopsy. Note thinning and discontinuity of bone Dr. Vincent Vigorita, State University of New York, Health Sciences
trabeculae. Coarsening of the trabecular pattern on radiographs and CT Center, Brooklyn, NY
regional migratory osteoporosis, and several other entities DXA, QCT, and quantitative ultrasonography (Table 2.1).
that will be discussed later in the appropriate sections of this Most but not all cases of diminished bone density result from
chapter. osteoporosis.
Osteomalacia arises when there is diminished mineraliza- In the following radiological classification (Table 2.1), we
tion of osteoid. There may be normal or excessive produc- consider other causes of diminished bone density in addition
tion of osteoid. The result is an alteration in the chemical to osteoporosis. This classification is complementary and not
composition of the bone with greater elasticity but lower ten- contradictory to WHO definitions of diminished bone den-
sile strength. Osteomalacia is diagnosed histologically by the sity, introduced in 1994.
presence of enlarged osteoid seams observed in decalcified Admittedly, this radiological classification is an
sections of the bone. oversimplification of a very complicated problem. For
Osteolysis is generally considered to be a focal loss of
bone in direct response to a pathologic process such as infec-
tion, neoplasm, other focal processes such as post-traumatic Table 2.1 Radiological classification of generalized diminished bone
clavicular osteolysis, a local manifestation of a systemic density (osteopenia)∗
disease such as distal clavicular osteolysis that occurs in Osteopenia
hyperparathyroidism and rheumatoid arthritis, or acrooste- Osteopenia is generalized diminished bone density (GDBD) of any
olysis of the digital tufts as observed in polyvinyl chloride cause or if the etiology is unknown. Osteopenia includes
osteoporosis, osteomalacia, and osteolysis
workers, scleroderma, epidermolysis bullosa, hyperparathy- Osteoporosis
roidism, frostbite, and thermal injury. The various forms of Osteoporosis is defined as a reduction of bone mass per unit
regional or focal osteolysis are covered in the appropriate volume (cubic centimeter). The chemical composition of bone is
chapters of this book. Here we confine our discussion to com- normal. Histologically, it is diminished osteoid∗∗ formation
paring osteoporosis with generalized osteolysis. This may be Osteomalacia
Osteomalacia is inadequate osteoid mineralization and chemical
caused by an osteoclast-activating hormone (OAH) (such as
composition of bone is changed
parathormone) or osteoclast-activating factors (OAFs) such Osteolysis
as the OAFs excreted by myeloma cells or in other types of Osteolysis is increased rate of bone resorption by osteoclasts or it
cancer cells. Generalized osteolysis may also be seen in mar- is caused by marrow proliferative and/or marrow packing
row packing disorders such as Gaucher disease. In this group disorders. The chemical composition of bone may or may not be
changed. This cause of diminished bone density may be
of patients, generalized diminished bone density (GDBD) is generalized or focal. In this classification we are interested in
neither due to osteoporosis nor due to osteomalacia. generalized form of this third group
We will use the general term of osteopenia to include the ∗ This classification takes into consideration pathophysiology of dimin-
three distinct forms of generalized diminished bone density ished bone density.
∗∗ Osteoid is bone matrix before calcification.
(GDBD), which are radiologically documented accurately by
2 Systematic Approach to Metabolic Diseases of Bone 19
example, aging osteoporotic patients also tend to have fracture than those who do not. Thus, prediction of
increased levels of plasma PTH. Age-related secondary osteoporotic fractures cannot been easily and accurately
hyperparathyroidism is a significant cause of diminished estimated.
bone density in elderly men and women due to calcium • The role of genetic factors in the pathogenesis of osteo-
and vitamin D deficiency. Intestinal absorption of calcium porosis is confirmed by epidemiological studies.
decreases with age. Synthesis of endogenous vitamin • Lifestyle risk factors for osteoporosis include alcohol
D decreases from aging of the skin and lower sunlight abuse, smoking, low calcium intake, and lack of physical
exposure. Furthermore, synthesis of [1,25(OH)2 D3] is also activity.
diminished from age-related reduction in the activity of • Chronic conditions such as Cushing disease, hemochro-
renal enzyme (1 α-hydroxylase). Consequently, calcium matosis, hypogonadism, gastrointestinal abnormalities
and vitamin D deficiency causes secondary age-related such as Crohn disease, and chronic pancreatitis predispose
hyperparathyroidism. the patients to osteoporosis.
On the other hand, patients with hyperparathyroidism, • Some drugs such as corticosteroids, thyroid hormone,
myeloma, or osteomalacia may also have secondary disuse antiandrogen treatment, and to a lesser extent heparin and
osteoporosis. Therefore, the distinction among these three loop diuretics cause osteoporosis.
types of GDBD is not always clear-cut. Nonetheless, this • The risk of developing fractures increases in condi-
classification provides a practical systematic approach to dif- tions that increase the possibility of fall such as neu-
ferentiate the main causes of generalized diminished bone rologic disorders, heart conditions leading to orthostatic
density GDBD and every type of generalized decreased bone hypotension, and in patients who are treated with neu-
density will not be considered osteoporosis as it is done in roleptics, antidepressants, and antihypertensive medica-
WHO definitions. tions.
These three processes may appear similar on radiographs
and DXA. Hence, the general term osteopenia is used when Much research has gone into measuring bone mineral
the etiology of GDBD is not known. It is important to content in order to determine on average when an indi-
remember that definition of osteopenia in this classification vidual is at risk for fracture. While many of these tests
is quite different from its definition in WHO definitions of give local measurements of BMD, no clinically practical
diminished bone density. available test gives information regarding the microarchi-
tecture of the bone. The architecture of bone is likely
to be as important in predicting fractures as is the abso-
lute amount of bone since the organization of the mate-
Osteoporosis rial will affect its overall strength. Recently, microcomputed
tomography and high-resolution MRI using SNR-efficient
Osteoporosis is the most common bone disease in humans sequences, high magnetic field (3 Tesla), and phased array
and affects both sexes. By definition, osteoporosis is nonfo- coils have been used for the in vivo study of the trabecular
cal diminished bone mass per unit volume of bone (cubic microarchitecture of bone, but these techniques at present
centimeter). are not clinically available. Others have used susceptibil-
Normal adults lose bone mass beyond the age of 40 ity effects to evaluate the overall directional components of
years by the process of involutional osteoporosis, which was bone.
described previously. This loss of bone begs the question Osteoporosis may be divided into primary or secondary
as to when the loss is pathologic and when it is physio- forms. Primary osteoporosis is age related and can be seen
logical. The practical answer to this question is that osteo- in both men and women. In secondary form of osteoporo-
porosis becomes pathologic when the patient is at risk for sis, bone loss is precipitated by a variety of chronic medical
fracture without major trauma. This risk will depend not conditions, medications, nutritional deficiencies, and other
only on the bone mass of the individual and the microar- causes.
chitecture of the bone but also upon several other factors There are multiple pathophysiological mechanisms that
as follows: lead to secondary osteoporosis. For example, certain amino
acids and vitamin C are necessary for osteoid synthesis. A
• Women at greatest risk for osteoporosis are Caucasian deficiency in these causes dietary osteoporosis. If the nec-
ectomorphs with low calcium intake, sedentary lifestyles, essary amino acids are depleted in the synthesis of sug-
little sun exposure, and early menopause. On the other ars (glycogenesis), as probably occurs in diabetes melli-
hand, those individuals who are more active or who tus and Cushing disease, or if the catabolic destruction
take more physical risks are clearly at greater risk for is greater than the supply, as in thyrotoxicosis, we might
20 A. Bonakdarpour
Radiographic evaluation
A B C
of patients with multiple myeloma have marked diffuse (such as Gaucher disease), hyperthyroidism, chronic immo-
and uniform diminished bone density without focal oste- bilization, hepatic insufficiency, diabetes mellitus, drug-
olytic lesions. This is related both to excretion of an induced osteoporosis from corticosteroids and heparin, drug-
osteoclastic-activating factor by myeloma cells and to mar- induced osteomalacia caused by anticonvulsant therapy,
row proliferation and packing by the tumor cells (Figs. 2.9 Cushing disease/syndrome, and rheumatoid arthritis also
and 2.10). Metastatic disease, osteomalacia, primary and cause decreased bone density and are in the differential diag-
secondary hyperparathyroidism, marrow packing disorders nosis of osteoporosis.
Fig. 2.5 Genants semiquantitative method for reading osteoporotic spine. From left to right: Wedge, biconcave, and crush deformities are
vertebral fractures. Vertebral body fractures are graded from 0 to 3 in demonstrated in normal and Grades 1–3 fractures
the assessment of osteoporotic fractures in lateral radiographs of the
2 Systematic Approach to Metabolic Diseases of Bone 23
A-7-28-88 B-11-21-88
Bone density must diminish by 30–40% before it is recog- accurate than both radiographs and DXA, but it is more dif-
nizable radiographically. For this reason, radiographs are not ficult to perform, less precise, and give the patient more radi-
sensitive to early loss of bone density. Radiographic appear- ation than DXA (Fig. 2.17).
ance of congenital forms of osteoporosis such as osteoge- The precision error of DXA (1–2%) is relatively high
nesis imperfecta (Fig. 2.11) are more or less similar to the compared with patients’ annual rate of bone loss or gain.
acquired forms. This entity is discussed in more detail in Thus, a 2-year interval between measurements is necessary
Chapter 13. for meaningful monitoring using this technique, in mon-
Dual X-ray absorptiometry (DXA), quantitative CT anal- itoring therapeutic efficacy. In the interval, follow-up of
ysis (QCT) and quantitative ultrasonography, though imper- osteoporotic patients may be done using standardized visual
fect, detect diminished bone density at a much earlier stage (or semiquantitative) assessments of vertebral deformities. In
of development than do radiographs. At present, DXA is the standardized assessment radiographs of the spine, numerical
most commonly used procedure for early detection of osteo- scores are assigned to vertebral deformities, and distinct
porosis (Figs. 2.13, 2.14, 2.15, and 2.16), primarily because categories are assigned to the shape or the type or the
its results are easily reproducible from one examination to severity of vertebral fractures in a definable and reproducible
another. manner. No measurements of vertebral dimensions are
Even so, radiographs still have a major role in the manage- made. This semiquantitative radiographic approach not only
ment of osteoporotic fractures and in the differential diagno- helps the clinical research of osteoporosis but also provides
sis of causes of decreased bone density. QCT is also more more practical accurate follow-up during treatment of this
a b
Fig. 2.7 Insufficiency fractures in a 78-year osteoporotic female. a is b is a T2-weighted axial MR image of the pelvis showing the same
a T1-weighted axial MR image of the pelvis showing an insufficiency fracture with increased signal intensity consistent with acuity (arrow).
fracture with decreased signal intensity of the left pubic bone (Arrow). Courtesy of Dr. Murali Sundaram, Cleveland Clinic, Cleveland, Ohio
24 A. Bonakdarpour
A B C
Fig. 2.12 Osteoporosis. MR a and b and CT c sagittal images in a 93- suggests a nonacute fracture. Sagittal reconstructed CT c performed at a
year-old osteoporotic man with compression fracture of the L3 vertebral later date showing diminished bone density, coarse vertical trabeculae,
body. Sagittal T1 MRI a shows deformity and decreased signal inten- severe progressive crush deformity, decreased height of central verte-
sity of the body of L3. Note enlarged spinous processes and decreased bral body, and a retropulsed fragment (arrow) into the spinal canal due
intraspinous distances of Baastrup phenomena, which contributed in to the progression of the Grade 3 fracture. Courtesy of Jeffrey P Kochan
part to the patients pain. T2 sagittal MRI b lack of T2 signal abnormality MD, Temple University Hospital, Philadelphia, PA
Fig. 2.13 Normal DXA followed for 6.5 years. A 75-year-old woman –0.1, –0.4, and –0.8, all within normal limits according to WHO def-
in 2007, normal follow-up DXA over 6.5 years. The patient had three initions. Courtesy of Dr. Alan Maurer, Temple University Hospital,
studies on 6/27/2000, 3/15/2005, and 11/20/2007. Lowest T scores: Philadelphia, PA
magnetic field, suggesting that MR measurements using this porosis. It is estimated that osteoporosis currently “affects
technique might also provide some information about bone 200 million women worldwide”. This makes osteoporosis
microarchitecture. Unfortunately, this technique is currently one of the most common diseases of the elderly. In 1988,
impractical for a number of reasons, including the size of the direct cost of osteoporotic fractures was estimated at 35
the scanner bore, the time it takes to complete the study, the billion dollars in the United States. In Europe the current
availability of the equipment, and the cost of MRI compared total direct cost is estimated to be over 31 billion Euros and
with DXA. may rise to a yearly cost of about 76 billion Euros by the
year 2050.
Low BMD, due to osteoporosis, is mainly age associ-
Osteoporosis Is a Major Public Health ated, but other factors such as low BMI, weight loss after
Problem the age of 25 years, lack of physical activity, poor nutri-
tion, tobacco smoking, chronic alcoholism, gastrectomy, cer-
The prevalence of osteoporosis increases with age. One out tain drugs (mainly corticosteroids, loop diuretics, thyroid
of three women between ages of 60 and 70 is osteoporotic. hormones) also contribute to declining bone mass. Post-
Two out of three women at age 80 are osteoporotic. In menopausal osteoporosis develops prematurely in young
1995, 9.4 million American women suffered from osteo- individuals who undergo oophorectomy (Fig. 2.18). Patients
28 A. Bonakdarpour
Fig. 2.14 Osteopenia DXA hip. Woman 48, lowest T score –2.1 consistent with osteopenia. Courtesy of Dr. Alan Maurer, Temple University
Hospital, Philadelphia, PA
may show as much as 12% bone loss in the 2 years following common type of osteoporotic fractures [1] (Figs. 2.3, 2.4, 2.5,
oophorectomy. 2.6, and 2.7).
About 1.5 million fractures in the United States are Hip fracture (Fig. 2.19a) is the most disastrous conse-
attributed to osteoporosis annually. They occur primarily in quence of osteoporosis. Its incidence increases exponentially
the spine, the hip, and the distal forearm. Approximately with age in both men and women. The risk of hip fracture
50% are vertebral, 20% in the hip, 20% in the wrist. At is increased in people with other common osteoporotic
age 60, women suffer osteoporosis-related fractures at a rate fractures, mainly vertebral and distal radius fractures. There
that is six times that of age-matched men. By 70 years are two main determinants of the risk of hip fracture: low
of age, osteoporosis is present in both genders, and the BMD and falls. Unfortunately, balance worsens as people
ratio of osteoporosis-related fractures declines to 2:1. The age and so falls become more likely.
estimated lifetime risk of sustaining an osteoporotic frac- Fracture of the distal radius (Fig. 2.19b) is the third most
ture is 40% for women and 13% for men at age 50 years. frequent osteoporotic fracture in women at age 80. It is also
The risk for hip fracture is 17.5% for women and 6% often one of the earliest manifestations of osteoporosis. In
for men. men over 65 years of age, the incidence of distal radius
The most common complaint from osteoporosis is back fracture is four times lower compared with women of the
pain. The onset may be insidious or sudden following same age.
injury. There is a definite relationship between osteoporosis Fracture of the proximal third of the humerus, particularly
and spinal compression fractures that occur spontaneously its surgical neck, is another common fracture in osteoporotic
or with minimal trauma. Vertebral fractures are the most patients.
2 Systematic Approach to Metabolic Diseases of Bone 29
Fig. 2.15 Osteoporosis DXA. Black woman 57, osteoporotic spine, the lowest spinal T score –3.5 and Z score –2.1. Courtesy of Dr. Alan Maurer,
Temple University Hospital, Philadelphia, PA
Prevention and Treatment of Osteoporosis treatment of osteoporosis. Most of these agents are in the
bisphosphonate class of drugs and act by decreasing bone
Prevention turnover.
Bisphosphonates (BP) – Bisphosphonates (BP) are potent
inhibitors of bone resorption that inhibit the activity of osteo-
Prevention of osteoporosis is based on nutritional factors and
clasts. These are commonly used in the treatment of post-
exercise. Dietary calcium should be about 800 mg per day
menopausal osteoporosis.
for adults and 1,500 mg per day for adolescents. Recom-
Hormone replacement therapy (HRT) – Hormone replace-
mended calcium intake for postmenopausal women is 1,000–
ment therapy (HRT), either estrogen alone or in combination
1,500 mg per day.
with progesterone, increases BMD at all skeletal sites in early
and late postmenopausal women. It is associated, however,
with an increased incidence of endometrial cancer (about
Treatment 1% per year) and other complications such as deep venous
thrombosis (DVT), pulmonary embolism, hypertension, and
Currently, prevention of bone loss is much more effec- gallstones. Therefore, it is indicated only in high-risk patients
tive than treatment of established osteoporosis. Nonethe- with evidence of rapid bone loss.
less, if detected at an early stage, osteoporosis is a poten- Selective estrogen receptor modulators (SERM) – Selec-
tially treatable disease. During recent years, several effec- tive estrogen receptor modulators (SERM) are synthetic
tive new drugs have been approved for the prevention and molecules that have the ability to bind to estrogen
30 A. Bonakdarpour
Fig. 2.16 Treated osteoporosis showing improvement. The patient was age of 66 to –1.1 in 2007 at the age of 73. Four DXA studies were
a white woman, treated with Fosamax (alendronate sodium) from July performed. Courtesy of Dr. Alan Maurer, Temple University Hospital,
2001 to November 2007. T score increased from –1.5 in 2001 at the Philadelphia, PA
Scurvy
receptors throughout the body and act as estrogen ago-
nists or antagonists depending upon the target organ. Ralox- Scurvy is caused by a deficiency in vitamin C (ascorbic acid)
ifene is the only SERM currently on the market for and is rarely encountered in the western hemisphere. Vitamin
osteoporosis. C deficiency results in an inability on the part of the finer
Calcium and vitamin D – Calcium and vitamin D are indi- ramifications of the vascular tree to contain blood, resulting
cated mainly for the prevention of bone loss in the elderly in a bleeding diathesis. Vitamin C is also essential in the
and are a useful adjunct therapy in osteoporosis. production of adequate normal intercellular collagen and
Teriparatide rhPTH – The first effective stimulator of organic bone matrix. Thus, its absence leads to osteoporosis.
bone formation, the recombinant 1–34 fragment of human The radiographic manifestations of infantile scurvy
parathyroid hormone [rhPTH(1–34)], has recently been (Figs. 2.21 and 2.22) reflect osteoporosis and hemorrhage.
approved. Alterations are first apparent and are most marked in areas in
which the enchondral growth of bone is most rapid, e.g., the centers becomes thicker than normal and, combined with the
wrists, knees, and costochondral junctions. thin, sparse trabeculae of the center, results in a radiographic
The zone of provisional calcification in the physeal plate appearance described as “ring epiphysis” or Wimberger ring
forms normally, but it shows increased density (Fig. 2.21b). (Fig. 2.21a).
This is known as the white line of Frankel. There is a radi- The bone cortex becomes thin as a consequence of bone
olucent band adjacent to the zone of provisional calcification, resorption and deficient periosteal new bone production. The
the so-called Trummerfeld zone or the “scorbutic zone.” This trabeculae become small as a result of continued resorption
band may be evident first at the periphery of the metaphysis of bone combined with defective formation of new bone.
and present as a notch at the metaphyseal margin, the cor- Many of the finer trabeculae completely disappear.
ner sign. Fractures through this zone superficially suggest In untreated scurvy, subperiosteal hemorrhage appears on
epiphyseal separations but are really subepiphyseal; hence, radiographs only as a vague, irregular shadow of soft tissue
healing occurs without disturbing the bone growth. These density adjacent to the cortex of the bone. Once the scurvy
fractures are responsible for lateral spurring at the end of the is treated and healing begins, the subperiosteal hematomas
shaft, the so-called Pelkin spur (Fig. 2.21a). calcify peripherally and appear as large juxtacortical densi-
Epiphyseal centers are affected in the same way as is the ties. This is probably one of the earlier radiographic signs of
metaphysis. The zone of provisional calcification around the healing.
2 Systematic Approach to Metabolic Diseases of Bone 33
A B
osseous abnormalities. Osteoporosis is noted early and is tor control induced by the inciting event leads to osteo-
associated with retardation of bone development, resulting in porosis. Precipitating factors are numerous and include soft
a retarded bone age. Periosteal new bone may also develop. tissue injury, arthritides, infection, fractures, sprains, dislo-
cations, and operative procedures. RSD has been reported
in association with central nervous lesions such as brain
Endocrine Osteoporosis tumors and severe head injury as well as myocardial infarc-
tion, cervical osteoarthritis, and other causes. These changes
Estrogen, androgens, or a combination of the two is usually affect an entire extremity or the distal portion of
necessary for normal osteoblastic activity. Hypogonadism an extremity such as hand or foot. It may occur along
related to ovarian agenesis (Turner syndrome) and testicular the distribution of a single nerve involving a portion of a
dysgenesis (Klinefelter syndrome) may be associated with hand.
osteoporosis. Radiological Findings: Early on radiographs of patients
Excess cortisol (the major adrenocorticoid) producing with RSD show only soft tissue swelling that corresponds
Cushing syndrome/disease may also lead to osteoporosis. to the clinical findings of swelling, vasomotor tissue discol-
Iatrogenic Cushing syndrome is caused by long-standing use oration, and hyperesthesia. Later the swelling decreases and
of corticosteroids in systemic diseases such as systemic lupus patients’ radiographs appear normal, or they show osteope-
erythematosus or rheumatoid arthritis. Besides osteoporosis, nia. Eventually, if not treated, the musculature of the affected
steroids may also cause ischemic necrosis of the bones, espe- part atrophies and patients develop osteoporosis.
cially femoral heads, humeral heads, and femoral condyles.
The osteoporosis that results from thyrotoxicosis is
believed to be caused by the high rate of catabolism of pro-
teins that it induces and hence a lack of substrate to form Osteogenesis Imperfecta
osteoid. Osteoporosis in diabetes mellitus occurs from diver-
sion of substrate proteins into much needed glycogen.
Osteogenesis imperfecta is discussed in Chapter 13. Please
see also (Fig. 2.11 )of this chapter.
A B
Fig. 2.27 Transient osteoporosis. Same patient as in Fig. 2.26. a is suppressed MR image showing increased signal intensity consistent
the axial T1-weighted MR image of the hips revealing decreased sig- with bone marrow edema (arrows). Courtesy of Dr. Mahvash Rafii,
nal intensity of the right femoral neck, extending to the femoral head, New York
and sparing the subchondral region. b is the axial T2-weighted, fat-
hip with normal or equivocal findings on radiographs (Figs. available calcium, phosphorus, or both in the fluid that per-
2.26, 2.27, 2.28, and 2.29). For further information, refer to meates osteoid. A number of mechanisms lead to this defi-
Chapter 5. ciency including inadequate dietary intake, defective absorp-
tion through the gut wall, and failure of the kidneys to con-
serve the mineral supply. During pregnancy and during the
Inadequate Osteoid Mineralization periods of accelerated growth, there is increased demand
for mineral and this may outstrip a tenuous level of intake.
A variety of skeletal diseases have normal or near-normal In other diseases such as hypophosphatasia and vitamin D-
osteoid production but mineralization is defective. More than dependent rickets, mineral supply may be normal but the
30 different etiologies cause clinical syndromes related to formed osteoid may not accept it.
disturbances of matrix mineralization. In the majority of The common denominator in all these conditions is a
these diseases, the pathology lies in an inadequate amount of lack of osseous rigidity (increased elasticity) in the immature
skeleton at sites of growth and in mature bones at points of
stress where turnover (physiologic lysis plus replacement) is
most rapid. Defective mineralization becomes apparent first
at sites of rapid growth because of the high rate of bone pro-
duction.
Several approaches have been used to classify the diseases
associated with osteomalacia. An etiologic approach is prob-
ably most practical. In a comprehensive review of the subject,
Mankin classified rickets and osteomalacia on a pathophysi-
ological basis. Table 2.4 represents a modified classification
of the most important of these diseases.
All these conditions are called rickets when they occur in
growing bone and osteomalacia if they involve the mature
skeleton. We discuss nutritional rickets and osteomalacia as
the archetype of most of these diseases, followed by discus-
sion of some of the more important specific diseases (Table
2.4).
Rickets
Fig. 2.28 Transient osteoporosis. The same case as Fig. 2.27. Coronal
STIR MR image also shows increased signal intensity consistent with
bone marrow edema of the right femoral head and neck. Courtesy of Dr. Rickets is a disturbance in the formation of bone in the grow-
Mahvash Rafii, New York ing skeleton caused by a failure of deposition of mineral
2 Systematic Approach to Metabolic Diseases of Bone 37
A B
Table 2.4 Etiological classification of rickets and osteomalacia within the organic matrix of cartilage and bone at the growth
1. Deficiency states plate. The failure may result from a deficiency in the dietary
a. Vitamin D deficiency intake of calcium or phosphorus to a failure of adequate
b. Calcium deficiency absorption through the gut wall or other causes presented in
c. Phosphorus deficiency
Table 2.4.
d. Solar irradiation deficiency
e. Rickets of prematurity
Because active rickets is manifested only in the growing
2. Absorptive skeleton, its expression is seen in the first period of rapid
a. Gastrointestinal abnormalities growth, between 6 months and 3 years, though its effect
b. Hepatobiliary disease may be encountered earlier. Less severe form rickets may not
c. Pancreatic abnormalities manifest themselves until the prepubertal years.
3. Hereditary renal tubular diseases (renal rickets) Economically advanced nations have learned that it is pos-
a. Vitamin D-dependent rickets (VDDR) sible to prevent nutritional rickets even among its less advan-
i. Autosomal recessive
taged citizens. Both calcium and phosphorus are ubiquitous
b. Vitamin D refractory rickets (VDRR)
i. X-linked dominant in milk and other dairy products. Today, an inadequate intake
ii. Autosomal dominant, recessive or sporadic (Rare) of vitamin D in infancy and early childhood is the most com-
c. Vitamin D refractory rickets with glycosuria mon cause of nutritional rickets. In lieu of sun exposure as a
d. Fanconi syndromes means to vitamin D formation, synthetic preparations of vita-
i. Autosomal recessive form min D, also in milk, have all but eliminated this form of rick-
ii. Lowe syndrome ets. Only in underdeveloped nations with low sun exposure,
iii. Wilson disease
populations suffering from famine and cults with dietary
iv. Tyrosinemia
v. Lignac-Fanconi syndrome
eccentricities does advanced rickets occur in numbers.
a. Renal tubular acidosis (distal tubular) Rarely severe fibrocystic disease of the pancreas or more
b. Autosomal dominant with variable penetrance often celiac disease may interfere with calcium absorption
4. Renal osteodystrophy (uremic osteopathy) to an extent that insufficient calcium is absorbed through the
5. Iatrogenic gut. In these diseases, calcium binds to fats and passes in the
a. Anticonvulsant therapy stool.
b. Intravenous hyperalimentation
Rickets has been reported in premature infants of very
c. Nonabsorbable antacids
d. Peritoneal dialysis
low birth weight with increasing frequency. The pathogen-
e. Hemodialysis (amyloidosis – B2 microglobulin – 100% esis is probably metabolic, nutritional, and in some cases
involvement in adults following 15 years of dialysis) iatrogenic.
6. Tumor related
7. Miscellaneous
a. Hypophosphatasia Radiological Manifestations
b. Vitamin D refractory rickets, type II
c. Atypical axial osteomalacia
Radiographic changes of rickets are best illustrated in the
long bones (Fig. 2.30). Although generalized osseous alter-
38 A. Bonakdarpour
ations occur, the first and most apparent are found at sites
where the growth of bone is most rapid, e.g., the wrist, knees,
and costochondral junctions (Fig. 2.31).
The earliest radiographic sign of rickets is haziness, fol-
lowed by disappearance, of the zone of provisional calci-
fication. Radiographic findings in the metaphysis are more
apparent because bone growth is most rapid in this por-
tion of long bones. Radiographically, the width and depth
of the radiolucent physeal cartilaginous matrix interposed
between the epiphyseal center and the metaphysis increases.
Attempts at ossification of the irregularly deposited osteoid
enhance the irregularity of the metaphyseal region, resulting
in a radiographic appearance that has been compared to the
bristles of a paintbrush. Cupping of the ends of diaphyses
of the bones probably results from mechanical factors acting
upon the soft, unmineralized osteoid at the metaphysis.
The smaller trabeculae may undergo complete resorption
so that the bones have nearly similar radiodensity as the soft
tissue marrow. For the same biomechanical reasons as in
osteoporosis, the trabeculae oriented along the lines of stress Fig. 2.31 Nutritional rickets. This is a different patient. AP radio-
accrue mineral and appear prominent. Defective mineraliza- graph of the chest demonstrating rachitic rosary more obviously on
tion leads to deceptively thick cortices, but they are made up the left
2 Systematic Approach to Metabolic Diseases of Bone 39
Prognosis
Fig. 2.32 Nutritional rickets. AP pelvis of another patient with nutri-
tional rickets after treatment. The proximal femoral epiphyses show
Ordinarily, the assurance of adequate intake of calcium and
remineralization. This phenomenon is not related to the growth of the
epiphyses, but it is demonstrating the result of treatment and partial phosphorus and the addition of vitamin D to the diet are
recalcification of the epiphyseal cartilage all that is required to treat nutritional rickets. If the disease
40 A. Bonakdarpour
A B
does not respond to dietary measures, then other confound- only from differences in the response of growing and mature
ing causes of the rickets should be sought. bone to a deficiency of calcium, phosphorus, or vitamin
D. Full-blown osteomalacia rarely occurs in the western
hemisphere.
Osteomalacia The causes of the inadequate mineral supplies for skele-
tal maintenance are listed in Table 2.4. Dietary deficiencies
Osteomalacia is a disease of mature remodeling bone. The severe enough to cause osteomalacia are rare in industrial
pathogenesis of osteomalacia is exactly the same as that of countries. Nevertheless, there are reports of osteomalacia
rickets. The differences between the two conditions result among vegetarians and diet faddists. There are also reports of
Fig. 2.36 Combined rickets and scurvy. AP radiograph of the left ribs
Radiological Manifestations
of the same patient as in Fig. 2.34 with combined rickets and scurvy.
Rosary of the costochondral junctions is a manifestation of both disor-
ders, but it is dense related to scurvy
Early in the course of osteomalacia, a coarse trabecular pat-
tern may be the only evidence of pathology. The coarse tra-
becular pattern is a consequence of inadequate mineraliza-
tion of secondary trabeculae; the larger primary trabeculae
osteomalacia in elderly people who eat poorly, the so-called are well seen in contrast with the unossified osteoid and
“tea and toast” diet. soft tissues of the marrow (Fig. 2.37). The weight-bearing
Dietary deficiencies are more common in economically
underdeveloped countries, among those who live on inad-
equate rations and those denied sunlight. Social practices
such as completely covering clothing in women in some
cultures in India and parts of Asia have been reported to
cause osteomalacia from lack of vitamin D as a result of
actinic rays deprivation.
Fat absorption disturbances that result from chronic dis-
ease of the bowel and pancreas may also result in osteomala-
cia. Chronic steatorrhea, sprue, fibrosing pancreatic disease,
disturbances in the biliary duct system, and long-standing
ulcerative colitis may result in conditions that inhibit the
absorption of fat-soluble vitamin D. Unabsorbed fatty acids
may form insoluble soaps with the available calcium in the
bowel. This in turn stimulates bowel motility, causes diar-
rhea, and moves the intestinal contents through the gut too
fast for efficient absorption. The net result is poor absorption
of vitamin D, calcium, and phosphorus from the bowel lumen
to the blood.
A rare type of osteomalacia, known as puerperal or mul-
tiple pregnancy osteomalacia, occurs in young women who
bear several children in rapid succession and nurse them
Fig. 2.37 Osteomalacia. There is diminished bone density, coarsening
between confinements. This practice depletes the skeletal
of the trabecular pattern of bones, and cortical thinning. In the absence
calcium and phosphorus stores in order to meet the demand of Looser zones and deformity, these findings alone do not establish
of the growing fetus and the nursing infant. diagnosis of osteomalacia
42 A. Bonakdarpour
Fort démontés par cet insuccès, les coalisés n'ont plus d'espoir
qu'en M. Thiers. Mais celui-ci, considérant la partie comme perdue et
préférant se réserver pour une meilleure occasion, demeure
immobile et silencieux. À sa place, on entend M. Passy dénoncer la
politique «décolorée et vacillante» du cabinet. M. Molé était sauvé.
Quelques mots de réplique lui suffisent pour clore le débat. Un
amendement de M. Boudet, tendant à réduire de 300,000 francs le
chiffre du crédit, est repoussé par 233 voix contre 184, et l'ensemble
de la loi est voté par 249 voix contre 133.
III
La coalition avait débuté par un gros échec. Elle n'en fut pas
dissoute; les alliés continuèrent à se concerter pour la formation des
commissions, pour la nomination des présidents de bureaux, mais
sans entrain, à mi-voix, la tête basse, comprenant que, pour le
moment, toute attaque de front était impossible. Du côté du cabinet,
au contraire, on triomphait. La presse officieuse, devenue
nombreuse, grâce aux subventions libéralement distribuées par M.
Molé[321], semblait vouloir précipiter la déroute par ses sarcasmes et
ses invectives. La Presse dénonçait ces «dix à douze ambitions
insurgées, non pas contre ce que fait le gouvernement, mais contre
l'idée de voir faire par d'autres mains ce que les leurs n'ont pas su
exécuter», ces «amours-propres qui ne peuvent s'accoutumer à
croire qu'on gouverne sans eux». Le Journal des Débats flétrissait ce
qu'il appelait «cette espèce d'émeute d'ambitions impatientes», et il
ajoutait, un autre jour: «Les coalisés s'évertuent à nous dire qu'il n'y
a pas de coalition; nous le savons bien! Nous l'avons déjà dit: ce
n'est qu'une émeute où se sont donné rendez-vous toutes les
prétentions, toutes les rivalités, toutes les jalousies.»
IV
Parmi les projets ainsi maltraités, on peut citer celui qui élevait à
dix mille francs la pension de la veuve du général Damrémont,
commandant en chef de l'armée d'Afrique, qui venait de succomber
héroïquement, en pleine victoire, sous les murs de Constantine:
circonstances exceptionnelles qui justifiaient le chiffre élevé de la
pension. M. Molé fut appuyé, cette fois, par M. Guizot et M. Thiers.
«Ne faisons pas dire, s'écria ce dernier, que le résultat d'un
gouvernement de discussion est de tout amoindrir, de tout
dessécher. Montrons au contraire qu'une grande nation peut discuter
ses affaires, sans devenir petite, sans refuser aux braves qui
meurent pour elle, la récompense qui leur est due... Si vous étiez
exposés à voir les finances de l'État compromises par des faits
semblables, à la bonne heure! mais quant à les voir compromises
par des actes héroïques, je suis rassuré: il n'y en aura jamais assez
pour que vos finances puissent périr.» Vainement toutes les autorités
gouvernementales et parlementaires, d'ordinaire divisées, se
réunissaient-elles dans un même effort, on put juger par le vote
combien peu elles pesaient devant l'«indépendance» des députés et
aussi devant leurs préventions mesquines. La majorité repoussa le
chiffre du gouvernement et ne vota qu'une pension de 6,000
francs[334].
Peu de questions étaient alors aussi importantes et urgentes que
celle des chemins de fer. La France se trouvait en retard sur plus
d'un pays voisin. Déjà, en 1837, le ministère Molé avait, sans succès,
présenté à la Chambre un premier projet d'ensemble. Il en présenta
un nouveau en 1838[335]. Le plan n'était pas sans hardiesse: il
comprenait neuf lignes principales, dont sept, partant de Paris,
aboutissaient à la frontière belge, au Havre, à Nantes, à Bayonne, à
Toulouse, à Marseille, à Strasbourg; les deux autres allaient de
Bordeaux à Marseille, et de Marseille à Bâle: soit onze cents lieues
de voies ferrées et une dépense d'un milliard. Pour le moment, on
n'en devait entreprendre que trois cent soixante-douze lieues. La
construction de ce réseau était réservée à l'État. La commission de
la Chambre fit mauvais accueil à ce projet[336]. Elle ne se contenta
pas de critiquer la construction par l'État, de manifester ses
préférences pour l'industrie particulière: sur ce point elle pouvait
avoir en partie raison; le rapporteur, M. Arago, blâma en outre
l'exécution d'ensemble: à son avis, l'art des chemins de fer était
encore dans l'enfance, et il y avait avantage à attendre, pour profiter
des découvertes que feraient les nations plus pressées que nous. La
discussion dura plusieurs jours[337]. Le président du conseil, le
ministre des finances et celui des travaux publics y prirent part. Le
résultat de leurs efforts fut le rejet complet du projet, à l'énorme
majorité de 196 voix contre 69[338].
VI
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
ebookball.com